MGC Diagnostics

MGC Diagnostics

Innovative technology for cardiorespiratory diagnostics, enhancing data collection, access, and review. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
CAD232m (Public information from Nov 2022)
Saint Paul Minnesota (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

IPO

N/A

Acquisition
*

$170m

Valuation: $170m

Acquisition
Total Funding-

Recent News about MGC Diagnostics

Edit
More about MGC Diagnosticsinfo icon
Edit

MGC Diagnostics Corporation specializes in advanced medical technology for cardiorespiratory diagnostics. The company serves healthcare providers, hospitals, and research institutions by offering state-of-the-art equipment and software solutions for pulmonary function testing and metabolic function analysis. Operating in the medical technology market, MGC Diagnostics generates revenue through the sale of diagnostic devices, software licenses, and ongoing service and support contracts. The company's business model focuses on continuous innovation and improvement, ensuring their products meet the evolving needs of the healthcare industry. Notable products include the Body 5500 device for body plethysmography and advanced software for data integration and analysis. MGC Diagnostics also collaborates with organizations like the European Space Agency to develop specialized instrumentation for space missions.

Keywords: cardiorespiratory, diagnostics, pulmonary function, metabolic function, healthcare, innovation, software, data integration, body plethysmography, medical technology.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by MGC Diagnostics

Edit
Lemon Medical
ACQUISITION by MGC Diagnostics Nov 2021